Signal transduction pathways of GM-CSF in neural cell lines

被引:20
作者
Choi, Jung Kyoung
Choi, Byung Hyune
Ha, Yoon
Park, Hyeonseon
Yoon, Seung Hwan
Park, Hyung Chun
Park, So Ra
机构
[1] Inha Univ, Coll Med, Dept Physiol, Inchon 400712, South Korea
[2] Inha Univ, Coll Med, Dept Neurosurg, Inchon 400712, South Korea
[3] Inha Univ, Coll Med, Inha Hosp, Inha Neural Repair Ctr, Inchon 400712, South Korea
[4] Inha Univ, Coll Med, Inha Res Inst Med Sci, Inchon, South Korea
关键词
GM-CSF; neural cells; Janus kinase (JAK) 2; signal transducer and activator of transcription (STAT) 5; extracellular signal regulated kinase (ERK);
D O I
10.1016/j.neulet.2007.03.065
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
GM-CSF is recently being suggested to play important role(s) in the nervous system. Present study was intended to understand signal transduction pathways of GM-CSF in human neuroblastoma (SK-N-(BE)2) and glioblastoma (A172) cell lines. The expression of GM-CSF receptors on the surface of these cells was confirmed by immunocytochemistry, Western blot analysis and RT-PCR. When treated for 10 min, GM-CSF activated the signal transducer and activator of transcription 5 (STAT5) and extracellular signal regulated kinase (ERK) in both cell lines. However, Janus kinase 2 (JAK2) was activated only in A172 cells but not in SK-N-(BE)2 cells by GM-CSF The GM-CSF-activated cellular signal pathways were specifically inhibited by the pretreatment of GM-CSF receptor a antibody, suggesting the specificity of the signal activation. The experiment using specific inhibitors (AG490) to the JAK/STAT pathway showed that JAK2/STAT5 cascade was well preserved and activated by GM-CSF in A172 cells, while STAT5 was activated by GM-CSF without JAK2 activation in SK-N-(EB)2 cells. The ERK pathway was activated by GM-CSF independently of JAK2 in both cell lines. Finally, GM-CSF showed cytoprotective effect on these cell lines by inhibiting cytotoxicity of saturosporine. The results revealed the signal transduction pathways activated by GM-CSF in neural cells and suggested that GM-CSF might affect the neural functions via these signal pathways. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:217 / 222
页数:6
相关论文
共 27 条
[1]   Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury [J].
Amar, AP ;
Levy, ML .
NEUROSURGERY, 1999, 44 (05) :1027-1039
[2]   Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor [J].
Armitage, JO .
BLOOD, 1998, 92 (12) :4491-4508
[3]   Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages [J].
Bouhy, Delphine ;
Malgrange, Brigitte ;
Multon, Sylvie ;
Poirrier, Anne-Lise ;
Scholtes, Felix ;
Schoenen, Jean ;
Franzen, Rachelle .
FASEB JOURNAL, 2006, 20 (08) :1239-+
[4]   mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response [J].
Chao, JR ;
Wang, JM ;
Lee, SF ;
Peng, HW ;
Lin, YH ;
Chou, CH ;
Li, JC ;
Huang, HM ;
Chou, CK ;
Kuo, ML ;
Yen, JJY ;
Yang-Yen, HF .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (08) :4883-4898
[5]   Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys [J].
Crowe, MJ ;
Bresnahan, JC ;
Shuman, SL ;
Masters, JN ;
Beattie, MS .
NATURE MEDICINE, 1997, 3 (01) :73-76
[6]   The distribution of granulocyte-macrophage colony-stimulating factor and its receptor in the developing human fetus [J].
Dame, JB ;
Christensen, RD ;
Juul, SE .
PEDIATRIC RESEARCH, 1999, 46 (04) :358-366
[7]   Recruiting the immune response to promote axon regeneration in the injured spinal cord [J].
David, S ;
Ousman, SS .
NEUROSCIENTIST, 2002, 8 (01) :33-41
[8]  
Feldmann M, 2001, CYTOKINE REFERENCE, P291, DOI DOI 10.1006/RWCY.2000.0204
[9]   Nervous system injury: focus on the inflammatory cytokine 'granulocyte-macrophage colony stimulating factor' [J].
Franzen, R ;
Bouhy, D ;
Schoenen, J .
NEUROSCIENCE LETTERS, 2004, 361 (1-3) :76-78
[10]  
Franzen R, 1998, J NEUROSCI RES, V51, P316, DOI 10.1002/(SICI)1097-4547(19980201)51:3<316::AID-JNR5>3.0.CO